RxDoctor Payments Data

Josh Sebag

Foot & Ankle Surgery · Port St Lucie, FLNPI 1881127348

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $250,542 of the $290,844 with a category attached, or 86.1%. Medartis Inc. accounts for 62.8% of it on its own, with 28 other manufacturers making up the rest. Reporting peaked in 2023 at $96,551 and has fallen 65.8% since, to $33,049 in 2025. Among foot & ankle surgery clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$290,844in general payments, 2019–2025

Across 314 payments — averaging $926.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medartis Inc.$183K
  • Fusion Orthopedics USA, LLC$39K
  • Nuvasive Specialized Orthopedics, Inc.$18K
  • Vilex LLC$17K
  • Globus Medical$7K
  • Stryker$6K
  • plus $21K from 23 others
$61,210in research payments, 2019–2025

Across 7 payments — averaging $8744.29 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medartis Inc.$61K

What the payments were for

  • Royalty or licence$7200%
  • Consulting fees$250,54286%
  • Speaking & faculty fees$5,7232%
  • Travel & lodging$17,1996%
  • Food & beverage$12,9884%
  • Education$3,6731%

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$290,844 in reported general payments places this provider in the 95th percentile of 850 foot & ankle surgery providers in Florida.

See all foot & ankle surgery providers in Florida

Medicare billing

Part B allowed, 2024
$150,101
Medicare patients
348
Services billed
4,314

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban89$36,658
Ondansetron Hcl86$1,647
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen127$1,633
Cyclobenzaprine Hcl108$906
Doxycycline Hyclate51$444
Ondansetron OdtOndansetron18$424
Meloxicam116$375
Methylprednisolone48$301
Diclofenac Sodium12$216
Gabapentin11$134
Ibuprofen13$121
Tramadol Hcl13$47

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Port St Lucie

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →